Biohit
3.69 EUR
+1.93 %
4,892 following
BIOBV
NASDAQ Helsinki
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Investor consensus
Valuation
Income statement
Quarterly estimates
Valuation
P/E (adj.)
Median 2020-2024
EV/S
Median 2020-2024
EV/EBIT (adj.)
Median 2020-2024
Dividend yield
Median 2020-2024
P/B
Median 2020-2024
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share price (EUR) | 2.96 | 3.36 | 2.48 | 1.84 | 1.57 | 1.92 | 2.29 | 3.69 | 3.69 | 3.69 | 3.69 |
| Shares | 15.0 | 15.0 | 15.0 | 15.0 | 15.0 | 15.1 | 15.1 | 15.1 | 15.1 | 15.1 | 15.1 |
| Market cap | 44.3 | 50.6 | 37.3 | 27.7 | 23.6 | 29.0 | 34.6 | 55.8 | 55.8 | 55.8 | 55.8 |
| Enterprise value | 35.3 | 41.9 | 31.6 | 22.3 | 18.3 | 24.5 | 29.8 | 48.7 | 47.1 | 44.7 | 41.9 |
| EV/S | 3.6 | 4.2 | 4.4 | 2.4 | 1.7 | 1.9 | 2.1 | 3.2 | 2.6 | 2.2 | 1.8 |
| EV/EBITDA | neg. | 70.5 | neg. | 44.0 | 11.4 | 11.7 | 10.4 | 17.0 | 13.9 | 10.4 | 8.5 |
| EV/EBIT (adj.) | neg. | neg. | neg. | neg. | 16.3 | 14.0 | 12.2 | 19.7 | 16.6 | 12.5 | 10.3 |
| EV/EBIT | neg. | neg. | neg. | neg. | 16.3 | 14.0 | 12.2 | 19.7 | 16.6 | 12.5 | 10.3 |
| P/E (adj.) | neg. | neg. | neg. | neg. | 39.3 | 16.6 | 12.9 | 26.6 | 23.0 | 18.5 | 16.4 |
| P/E | neg. | neg. | neg. | neg. | 39.3 | 16.6 | 12.9 | 26.6 | 23.0 | 18.5 | 16.4 |
| P/B | 2.8 | 3.4 | 4.2 | 3.8 | 3.1 | 3.1 | 2.8 | 3.9 | 3.4 | 3.0 | 2.7 |
| P/S | 4.5 | 5.0 | 5.2 | 3.0 | 2.2 | 2.2 | 2.4 | 3.6 | 3.1 | 2.7 | 2.3 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.9 % | 1.3 % | 1.6 % | 1.8 % |
| Equity ratio | 89.7 % | 84.4 % | 81.6 % | 76.7 % | 68.7 % | 73.1 % | 79.0 % | 75.7 % | 76.4 % | 77.1 % | 77.8 % |
| Gearing ratio | -55.7 % | -59.2 % | -64.7 % | -72.4 % | -69.8 % | -47.6 % | -39.6 % | -49.3 % | -53.7 % | -59.6 % | -66.2 % |